Transbiomed Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Transbiomed General Information


Developer of non-invasive molecular diagnostic therapies. The company is focused on biomarker discovery and development through to industrial prototyping, final product design and pivotal clinical trials, then licensing its products to large pharmaceutical companies for commercialization.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Primary Office
  • Parc Científic de Barcelona, Edifici Helix
  • Baldiri Reixac, 15-21
  • 08028 Barcelona
  • Spain
+34 934 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Transbiomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 08-Feb-2013 00.000 Completed Product Development
1. Early Stage VC 17-Feb-2011 00.000 00.000 Completed Product Development
To view Transbiomed’s complete valuation and funding history, request access »

Transbiomed Executive Team (1)

Name Title Board Seat Contact Info
Julia Winter Chief Executive Officer
To view Transbiomed’s complete executive team members history, request access »

Transbiomed Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ACC1Ó Government Minority 000 0000 000000 0
Inveready Technology Investment Group Venture Capital Minority 000 0000 000000 0
Ministry of Science and Innovation Government Minority 000 0000 000000 0
To view Transbiomed’s complete investors history, request access »